Italy
· Delayed Price · Currency is EUR Pharmanutra Company Description
Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, Europe, the Middle East, South America, Far East, and internationally.
It also produces and markets pharmaceuticals, medical devices, OTC products, and nutraceuticals for pediatric sector; and produces and distributes raw materials and active ingredients for the food, pharmaceutical, and food supplement industries.
The company’s products primarily include SiderAL, SiderAL Forte, SiderAL Folic, Cardio SiderAL, SiderAL Med, Cetilar Crema, Cetilar Patch, Cetilar Tape, Cetilar Oro, Cetilar Nutrition, ApportAL, UltraMag, Gestalys DHA, Novomega, Bonecal, and DiKappa 2.
It distributes and sells its products through sales representatives, wholesalers, pharmacies, and para-pharmacies.
The company was founded in 2003 and is based in Pisa, Italy.
| Country | Italy |
| Founded | 2003 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 105 |
| CEO | Roberto Lacorte |
Contact Details
Address: Via Campodavela 1 Pisa, 56122 Italy | |
| Phone | 39 05 07 84 65 00 |
| Website | pharmanutra.it |
Stock Details
| Ticker Symbol | PHN |
| Exchange | Borsa Italiana |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | IT0005274094 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Andrea Lacorte | Chairman and President |
| Roberto Lacorte | Vice Chairman, MD and Vice President |
| Carlo Volpi | Delegate Advisor, Chief Operating Officer and Executive Director |
| Germano Tarantino | Scientific Director and Executive Director |